ARCT Financials
Arcturus Therapeutics Holdings Inc - Financial statements & key metrics
Stock Price
$6.39
Market Cap
$181.62M
EPS
$-2.31
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$152.31M
Gross Profit
-
Operating Income
-
Net Income
$-80.94M
EPS (Diluted)
$-3.00
Balance Sheet Highlights
Total Assets
$344.07M
Total Liabilities
$103.09M
Shareholders Equity
-
Cash & Equivalents
$237.03M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-59.75M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Gross Margin
-36.8%
Operating Margin
-4.4%
Net Margin
-0.8%
ROE
-0.3%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is ARCT revenue?
ARCT's most recent quarterly revenue was $152.31M. Annual revenue can be calculated by summing the four most recent quarters.
Is ARCT profitable?
ARCT reported a loss of $80.94M in the most recent quarter. The net profit margin is -0.8%.
What is ARCT market cap?
ARCT has a market capitalization of $181.62M, making it a small-cap stock.
Does ARCT have debt?
View ARCT's balance sheet for debt information.
What is ARCT cash flow?
Cash flow data is available in the full financial statements.